Literature DB >> 15108777

Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease.

Anil S Paramesh1, Sasan Roayaie, Yvette Doan, Myron E Schwartz, Sukru Emre, Thomas Fishbein, Sander Florman, Gabriel E Gondolesi, Nancy Krieger, Scott Ames, Jonathan S Bromberg, Enver Akalin.   

Abstract

BACKGROUND: Acute renal failure (ARF) occurs in 5-50% of patients undergoing orthotopic liver transplantation (OLT). The aim of this study was to determine factors that might predict the development of end stage renal disease (ESRD) in patients who had ARF after OLT.
METHODS: We studied all OLT recipients between 9/1/1988 through 12/31/2000.
RESULTS: A total of 1602 patients underwent OLT during the study period. About 350 patients (22%) developed ARF requiring dialysis post-operatively. One hundred and twenty-three (39.8%) died within a year after OLT. Median follow up was 5.8 yr (range 1-12 yr). Forty-three patients (23%) developed ESRD over median of 3.79 yr (range 1-8 yr). Multivariate logistic regression analysis revealed creatinine levels > 1.7 mg/dL at 1 yr (p < 0.001), cyclosporine as immunosuppression (p = 0.026), and the presence of diabetes pre-OLT (p < 0.001) to be associated with the development of ESRD. The development of ESRD did not decrease patient survival (p = 0.111). ESRD patients who received subsequent kidney transplantation had significantly improved survival rates (p = 0.005).
CONCLUSIONS: Serum creatinine levels at 1 yr, cyclosporine as immunosuppression, and the presence of diabetes pre-OLT are independent predictive factors for the development of ESRD. ESRD patients who received kidney transplantation had higher 10-yr survival rates when compared with patients maintained on dialysis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108777     DOI: 10.1046/j.1399-0012.2003.00132.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  25 in total

1.  Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.

Authors:  Darshika Chhabra; Anton I Skaro; Joseph R Leventhal; Pranav Dalal; Gaurav Shah; Edward Wang; Lorenzo Gallon
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

2.  [Intensive care treatment following transplant surgery].

Authors:  S Kohler; A Pascher; P Neuhaus
Journal:  Chirurg       Date:  2006-08       Impact factor: 0.955

3.  Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review.

Authors:  William R Hand; Joseph R Whiteley; Tom I Epperson; Lauren Tam; Heather Crego; Bethany Wolf; Kenneth D Chavin; David J Taber
Journal:  Anesth Analg       Date:  2015-03       Impact factor: 5.108

4.  Intensive care management of liver transplanted patients.

Authors:  Paolo Feltracco; Stefania Barbieri; Helmut Galligioni; Elisa Michieletto; Cristiana Carollo; Carlo Ori
Journal:  World J Hepatol       Date:  2011-03-27

5.  Progressive pulmonary calcification in a child after orthotopic liver transplantation.

Authors:  Olena O Weaver; Madelyn M Stazzone; Sanjeev Bhalla
Journal:  Pediatr Radiol       Date:  2006-03-28

6.  Underestimation of chronic renal dysfunction after liver transplantation: ICEBERG study.

Authors:  Evaristo Varo; Rafael Bañares; Magda Guilera
Journal:  World J Transplant       Date:  2015-03-24

7.  Incidence and risk factors for early renal dysfunction after liver transplantation.

Authors:  Patricia Wiesen; Paul B Massion; Jean Joris; Olivier Detry; Pierre Damas
Journal:  World J Transplant       Date:  2016-03-24

8.  Comparing 10-yr renal outcomes in deceased donor and living donor liver transplants.

Authors:  Shaifali Sandal; Anthony Almudevar; Sandesh Parajuli; Anirban Bose
Journal:  Clin Transplant       Date:  2015-11-05       Impact factor: 2.863

9.  A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT.

Authors:  Armin D Goralczyk; Andreas Schnitzbauer; Tung Y Tsui; Giuliano Ramadori; Thomas Lorf; Aiman Obed
Journal:  BMC Surg       Date:  2010-04-09       Impact factor: 2.102

10.  Study protocol: a pilot study to determine the safety and efficacy of induction-therapy, de novo MPA and delayed mTOR-inhibition in liver transplant recipients with impaired renal function. PATRON-study.

Authors:  Andreas A Schnitzbauer; Marcus N Scherer; Justine Rochon; Johannes Sothmann; Stefan A Farkas; Martin Loss; Edward K Geissler; Aiman Obed; Hans J Schlitt
Journal:  BMC Nephrol       Date:  2010-09-14       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.